The transmembrane isoform of Fc gamma RIII, Fc gamma RIIIA, is found on NK cells, cultured monocytes, and tissue macrophages in association with a dimer of an accessory subunit, either gamma or zeta. Functions of individual Fc receptors have been difficult to analyze due to coexpression of the receptors on hematopoietic cells and permanent cell lines expressing Fc receptors. cDNAs for the alpha and gamma subunits of Fc gamma RIIIA were cotransfected into COS-1 cells, which lack endogenous Fc receptors, to evaluate receptor-mediated phagocytosis and changes in [Ca2+]i. Transfectants both bound and phagocytosed IgG-sensitized erythrocytes and, following activation of Fc gamma RIIIA, increased [Ca2+]i. The gamma subunit was essential both for the surface expression of the receptor and for transduction of the phagocytic signal. Truncation of the gamma subunit cytoplasmic domain (amino acids 65-80) eliminated phagocytic function. Phorbol ester inhibited phagocytosis in a concentration-dependent manner, but did not affect IgGsensitized erythrocytes binding, suggesting that a protein kinase C-dependent pathway inhibits phagocytosis. The data indicate that a tyrosine containing cytoplasmic domain within the gamma subunit is required for phagocytosis by Fc gamma RIIIA.
Introduction
Receptors for the Fc portion ofIgG are expressed on many cells ofhematopoietic lineage. These receptors are important in host defense and in the ingestion of IgG-coated cells ( 1, 2) . There are three classes of human Fcy receptors (FcyRI, FcyRII, and Fc7yRIII), distinguished by IgG subclass affinity, cellular distribution, and reactivity with monoclonal antibodies ( 1) . The genes for these receptors have homology in the coding regions for their extracellular domains, but are divergent in their transmembrane and cytoplasmic regions, suggesting functional specificity for the individual receptors. FcyRIII (CD16), a low affinity Fc receptor, has two isoforms that are encoded by two highly homologous genes (3, 4) . FcyRIIIB is found only on neutrophils as a glycosyl phosphatidylinositol-linked protein (5) . FcyRIIIA is found on NK cells, cultured monocytes and macrophages (6, 7) . The receptor is a multichain complex composed ofa ligand-binding polypeptide, a, and a disulfide-linked dimer of an accessory subunit, y or D. The y and r subunits were originally identified as components of other multimeric receptors, the high affinity receptor for IgE (FcERI)' and the T cell receptor (TCR / CD33), respectively (8) (9) (10) .
Examination of the functions ascribed to the individual Fcy receptors and their signal transduction pathways has proven difficult due to coexpression of more than one class of receptor on hematopoietic cells that express Fc receptors. Further complexity is added by various isoforms ofFcyRIIIA. The FcyRIIIA-a polypeptide associates with a dimer of y-y, tR, or ,ys that likely interacts with different second messenger pathways and subserve different functions upon immune complex binding ( 1) .
A previous report indicated that the fibroblast-derived COS-1 cell line possessed the cellular machinery for phagocytic cell function following Fc receptor ( 11 ) and mannose receptor transfection ( 12) . We used COS-1 cells to evaluate the phagocytic function ofthe Fc'yRIIIA complex, composed ofan a and a homodimer of y. We observed that COS-1 transfectants phagocytosed IgG-sensitized cells and that the cytoplasmic domain of its y subunit is required. In addition, we undertook studies with a known inducer of protein kinase C (PKC), PMA, to begin to dissect the signaling pathway involved in phagocytosis by this FcyRIIIA isoform.
Methods
Cell culture. COS-I cells were maintained in DMEM-high glucose (4.5 mg/ml), glutamine (25 mg/ml), penicillin ( 100 U/ml), streptomycin (100 gg/ml) and 10% heat-inactivated FCS at 37°C with 5% CO2. Cells were seeded onto 3.5-cm plates or six-well plates (Falcon Labware, Oxnard, CA) at a concentration of 3 x I05 cells/well, 24 h before transfection. The cells reached approximately 80% confluence for transfection. All tissue culture reagents were obtained from the University of Pennsylvania Tissue Culture Facility.
Construction ofrecombinant plasmids. The coding sequence of the Fc-yRIIIA-a cDNA (kindly provided by Dr. Bice Perussia, Jefferson College of Medicine, Philadelphia, PA) was ligated into the SV40driven eukaryotic expression vector pSVL (Pharmacia LKB, Piscataway, NJ) digested with XbaI and Sacd. The cDNA for the murine FcERI y-subunit (kindly provided by Dr. Jean-Pierre Kinet, National Institutes of Health, Bethesda, MD) was expressed from the same vector.
Truncation mutants of the 'y subunit were constructed by using the two-step overlap-extension PCR ( 13) . GAMdel-1, a mutant with the truncation at Lys8', was generated by changing the codon AAG for Lys to TAG for a termination. GAMdel-2, a mutant with the truncation at Tyr65, was generated by changing the codon TAC for Tyr to TAG for a termination.
Transient transfection of COS-J cells. Cotransfections of cDNAs were carried out with a modified DEAE-dextran method. Briefly, 300,000 COS-1 cells were seeded on 35-mm well plates, 24 h before transfection. Plates of 70-80% confluency were washed twice and incubated for 40 min with DMEM (GIBCO BRL, Grand Island, NY) with-out serum before transfection. 4 ,gg of plasmid DNA (0.5 ,g/,4l) was slowly added to 1 ml of a transfection buffer containing Nu medium (DMEM with 10% NuSerum [Collaborative Biomedical, Bedford, MA]), 1 mg/ml of DEAE-dextran and 100 juM chloroquine. The transfection buffer containing DNA was added to COS-1 cells with incubation for 4 h at 370C. Cells were then shocked with 10% DMSO in PBS for 2 min, washed twice with DMEM, and grown in Nu medium. Cells were studied 48 h following transfection.
Antibodies. Anti-FcyRIII monoclonal antibody 3G8 (14) was isolated from ascites fluid (the 3G8 hybridoma cell line was kindly provided by Dr. J. Unkeless, Mt. Sinai Medical School, New York, NY) using protein A (Affi-Gel Protein A Maps II; Bio-Rad Laboratories, Richmond, CA). The ascites fluid ( 1.5 ml) was applied to a 5-ml protein A agarose column. The column was washed with 15 vol ofbinding buffer, and the IgG was eluted according to manufacturer's instructions. The eluted protein was dialyzed against PBS and concentrated to 7 mg/ml. Flow cytometry. Anti-FcyRIII mAb 3G8 was used to assess protein expression on the cell surface of transfected COS-1 cells. Cells were gently removed from plates, counted, and resuspended in 50 z1 staining buffer ( lx PBS without Ca2"/Mg2", containing 0.02% sodium azide, 0.1% BSA) with 5 ,d ofprimary antibody and placed on ice for45 min.
After two washes, FITC-labeled F(ab')2 goat anti-mouse IgG (GAM) was added and incubation continued at 4°C for 30 min. Isotype controls were used for all reactions. Fluorescencewao measured on a FAC-Star® (Becton Dickinson & Co., Mountain View, CA). For all samples, 10,000 events were recorded on a log fluorescence scale and mean fluorescence intensity data and contour maps were generated. Electron microscopy. COS-1 cells were removed from plates by pipetting and washed to remove media. The pelleted specimens were fixed in 2% glutaraldehyde in 0. II, 3 dent-Newman-Keuls test for comparing means in a multitreatment study using the Primer ofBiostatistics (McGraw-Hill, Inc., New York) for the Apple Macintosh Plus. Effect of PMA on phagocytosis in COS-1 transfectants. PMA (Sigma Chemical Co., St. Louis, MO) was dissolved in DMSO. COS-l transfectants were incubated with increasing concentrations of PMA for 30 min followed by incubation with EA for 40 min. COS-1 cells were washed extensively, extracellular EA removed, and the cells analyzed for internalized EA as described above.
Measurement of[Ca2]i following FcyRIIIA activation. 48 h following transfection with the FcyRIIIA-a and -y cDNAs, cells adherent to 2.5-cm glass cover slips were taken for single-cell measurement of [Ca2+]i following cross-linking of FcyRIIIA (15) . Media were aspirated and replaced by HBSS with Fura-2/AM (Molecular Probes, Inc., Eugene, OR). Cells were incubated for 30 min at 370C, washed, and preincubated for an additional 30 min with biotinylated anti-Fc'YRIII mAb 3G8. The cover slip was transfered to a Leidem cell chamber (Medical Systems, Greenvale, NY) and individual cells were analyzed for a rise in [Ca2+]i following delivery by a micropipette of 50 Ag/ml streptavidin. Fluorescence was imaged with a 100 Fluor objective and a Diaphot epifluorescence microscope (Nikon Inc., Melville, NY). Emission was collected at 520 nm by a photomultiplier tube connected to a Johnson Foundation Spinning Wheel Fluorimeter (University of Pennsylvania Biomedical Instrumentation Group, Philadelphia, PA) and digitally analyzed by an IBM AT clone-based system (Indec Systems, Sunnyvale, CA). In control experiments only streptavidin or biotinylated mAb anti-FcyRIII was added to the above cells and mock transfectants.
Results
Cell-surface expression oftransfected Fc-yRIIIA. Expression of Fc-yRIIIA complexes 48 h after transfection was determined by flow cytometry using anti-FcyRIII mAb (Fig. 1 A) . Surface expression ofthe FcyRIIIA-a protein required interaction with the accessory subunit y, as previously noted (16) (17) (18) . Two deletion mutants of the -y chain were constructed by introducing stop codons at amino acids 80 (GAMdel-l mutant) or 65 (GAMdel-2 mutant) ( Fig. 1 B) . The cDNAs of these two mutants or wild type y along with the cDNA of a were cotransfected into COS-1 cells and examined for cell-surface expression of transfected receptor complexes. COS-1 transfectants containing wild type or mutant y exhibited comparable levels of FcyRIIIA assessed by mean fluorescence intensity and the percentage cells binding EA. Approximately 36% of the COS-I transfectants containing wild type or mutant y avidly bound EA (Table I) .
Phagocytosis and binding of EA mediated by FcyRIIIA. We examined COS-1 transfectants containing FcyRIIIA for their ability to bind and phagocytose IgG-sensitized cells. We and others have demonstrated phagocytosis of EA in COS-1 cells and other cell lines derived from fibroblasts, following Fc receptor transfection ( 1 1, 19) . In this study, we employed electron microscopy to examine phagocytosis in COS-1 cells cotransfected with the FcyRIIIA a and y subunits. The thin-section electron micrograph demonstrates that COS-1 cells that lack endogenous expression ofFc receptors are able to phagocytose EA when transfected with FcyRIIIA ( Fig. 2 A) . Light microscopic visualization of Wright-Giemsa-stained COS-1 transfectants also revealed phagocytosis of EA. The ingested EA have been found to be enclosed in distinct vesicles, with some RBCs showing partial degradation. Transfectants expressing both the a and y chains showed a substantial degree of EA binding (-36% of cells) and phagocytosis (-9% of cells) (Table I, Fig. 2 B) . Control transfectants, transfected with Fc-yRIIIA-a and pSVL vector without the y chain cDNA, did not exhibit binding of EA (< 1% of cells).
Internalization of EA was a time-dependent process and increased significantly from 15 to 60 min of incubation. There was approximately a fourfold increase in the phagocytic index at 60 min in comparison to 15 min (data not shown).
-y Chain is essentialfor phagocytic signal transduction. Although the surface expression ofthe FcyRIIIA a chain requires the y chain, it is not known whether -y is also involved in the signal transduction events required for phagocytosis. To examine its role in transduction ofa phagocytic signal, y wild type or mutants were cotransfected into COS-l cells along with Fc-yRIIIA a. The GAMdel-1 mutant, containing the COOH terminus 7 amino acid deletion, exhibited a 16% decrease in phagocytic activity. However, the GAMdel-2 mutant with the COOH terminus 22 amino acid deletion completely lost its ability to transduce a phagocytic signal (Table I ), suggesting that the cytoplasmic region spanning Tyr65 to Leu79 is critical for the phagocytic signal. These results demonstrate that the Y chain is essential not only for the surface expression of the a chain but also for the phagocytic function of the receptor.
The effect ofPMA on phagocytosis. Previous studies have shown that treatment of PMA increases FcyRIIA mediated phagocytosis in neutrophils and HEL cells (20, 21) . In this study, addition of PMA (10-6_10-'0 M) progressively decreased phagocytosis in transfectants expressing Fc7RIIIA, with more than a fivefold decrease observed at l0-7 M. In contrast, transfectants expressing FcyRIIA exhibited an increase in phagocytic function at lower concentrations (10`1 and I0 -9 M) followed by a modest decrease at higher concentrations (10-8 and 10-6 M) (Table II) . The effect of PMA depended upon its presence during EA incubation and was rapidly reversible. This effect of PMA on phagocytosis suggests that FcyRIIIA and FcyRIIA may mediate their phagocytic signals through different pathways. PMA had no effect on the percentage of COS-l cells binding EA by either receptor.
[Ca2]i stimulation following cross-linking of FcyRIIIA. To assess changes in [Ca2+ JI, we performed single-cell measurements. Upon cross-linking of FcyRIIIA with biotinylated anti-Fc-yRIII and streptavidin, [Ca2]i rose immediately to 2.5-to 7-fold over baseline in 6 out of 24 cells randomly tested (Fig.  3) . However, none of 23 mock-transfected cells exhibited an increase of [Ca2+ ] i flux when incubated with biotinylated anti-Fc-yRIII and streptavidin (data not shown). Streptavidin alone PMA was added to cells 30 min before incubation with EA and was present during EA incubation. EA was allowed to bind to transfectants for 40 min before staining. Results are expressed as the mean PI±SEM, n = 5, P < 0.05. For experiments with Fc-yRIIA, 2 gg of pSVL containing Fc-yRIIA and equal amounts of the vector DNA without insert were transfected into COScells. For FcYRIIIA, 2 Og each of pSVL containing cDNAs of a and y cDNA were used for cotransfection. did not stimulate a rise in [Ca2+Ji. Epinephrine (10 IAM), which evokes a Ca2" signal in COS cells (22) also stimulated a rise in [Ca2+]i (Fig. 3 ).
Discussion
Human FcyRIIIA is a receptor complex composed of three separate polypeptide chains, the ligand-binding subunit Fc'yRIIIA-a, and its associated -y and r chains found on NK cells, activated monocytes, and macrophages (23). These associated chains belong to a family of polypeptides that dimerize, interact in a noncovalent manner with other polypeptides in multimeric receptors, and are critical for signal transduction by the individual receptors (24, 25) . The y and r chains are required for surface receptor expression of FceRI and TCR/ CD3, respectively (8) (9) (10) . It has recently been shown that the y or r subunit significantly increases FcyRIIIA-a surface expression in cotransfection experiments (16, 18) . Without the interaction of the y or r molecule, the a chain is targeted for degradation in the endoplasmic reticulum (23). FcyRIIIA can exist in three molecular forms with the a chain associated with either yy, Id, or -ye. The FcyRIIIA-a-,yy isoform is found in macrophages, while all three forms occur in NK cells that express both the y and r subunits (26, 27) . We chose to evaluate the role of one specific isoform, Fc-yRIIIA-a--yy, in signaling following binding of Fc-yRIIIA by IgG-coated erythrocytes (EA) or anti-FcyRIII mAb in a transient transfection system. Prior studies evaluating individual Fc receptor functions have relied upon the use ofcells expressing more than one class of Fc receptor and receptor-specific IgG subclasses or mAbs to simulate ligand binding. Under these conditions, the relative binding specificity, displacement of mAbs by immune complexes, or cooperativity between the cytoplasmic domains of the different Fc receptor classes may influence the results. Fc receptor-negative COS-1 cells have previously been shown to be an effective transfection system for evaluating mannose receptor ( 12) and for individual Fc receptor function (1 1, 19) . Thus, analysis of Fc receptor signaling in this system can occur without the potential interpretation that the cytoplasmic domains of different receptors interact following ligand binding. Our results obtained with thin-section electron microscopy further demonstrate that COS-1 cells are an attractive model system to study the phagocytic signal transduction pathway.
COS-1 cells cotransfected with a and y (wild type and mutants) subunits of FcyIIIA demonstrated comparable levels of cell-surface expression of the multimeric FcyRIIIA (Table I) . Transfection of cells with FcyRIIIA-a chain alone did not induce its cell-surface expression. Thus, our data indicate that the -y chain is necessary for both the surface expression of Fc'yRIIIA and its transmission of a phagocytic signal. During the preparation of our manuscript, it was shown by others that the y subunit ofFcyRIIIA plays a critical role in antigen presentation in transformed B cells (28) and in Ca2l signaling in transfected T and mast cells (29) . Our results further demonstrate that the -y subunit of FcyRIIIA is essential for the signal transduction ability ofthis receptor. It is ofnote that the region deleted in the GAMdel-2 mutant contains two conserved tyrosines and leucines present in several signaling molecules ofthe immunoglobulin gene superfamily (30, 31 ) .
An increase in [Ca2+]i was demonstrated with COS-l cells expressing wild type FcyRIIIA a and y following receptor cross-linking, suggesting that the FcyRIIIA-a--y isoform can initiate events involved in Ca2+ mobilization. The cytoplasmic domain required for a phagocytic signal, described above, also appears to play an important role for intracellular Ca2+ mobilization, as mutants of the Sy chain in which tyrosine was replaced by phenylalanine exhibited significant reductions in intracellular Ca2+ mobilization (31a). Intracellular Ca2+ increases have been demonstrated for all three Fcy receptor classes (2, 32, 33). Similarly, it has been observed that both TCR/CD3 isoforms, CD3D and CD3n, also transmit signals responsible for Ca2" mobilization (24) .
The FcyRIIIA-a-,yy isoform mediated both binding and phagocytosis of IgG-sensitized erythrocytes in COS-1 transfectants without the presence of other Fc receptors. Since FcyRIIIA is an abundant Fcy receptor on macrophages and the -y chain is the only member of its family expressed in these cells, these experiments suggest that the FcyRIIIA-a-y'y isoform in macrophages plays an important role in phagocytosis.
This process may involve increases in intracellular Ca2" (34) . In NK cells, different Fc7RIIIA signaling pathways involved in ADCC and NK-cell activation may be mediated by oy or ¢ isoforms.
Through stimulation of the second messenger pathway involving PKC, PMA can affect events in the phagocytic process (20, 21 ) . We evaluated the effects of PMA on phagocytosis in COS-1 transfectants expressing either FcyRIIIA or Fc-yRIIA.
PMA ( l0-7 M) has been known to elicit superoxide anion production in U937 cells (35) and to stimulate both complement receptor-mediated phagocytosis in cultured monocytes (36) and FcyRII-mediated phagocytosis in neutrophils and HEL cells (20, 21 ) . However, the same concentration of PMA (10-7 M) caused an 82% reduction of phagocytosis in COS-1 transfectants expressing FcyRIIIA, while phagocytosis was reduced only by 13% in FcyRIIA transfected cells. That FcyRIIA transfectants consistently show moderate increases at 10-1o-10-9 M of PMA suggests that there are differences between these two Fcy receptors in intracellular signaling. These receptors may mediate phagocytosis in macrophages and stimulate monocytes by coupling with different second messenger pathways. PKC upregulation may be able to stimulate the FcyRIImediated pathway, while inhibiting phagocytosis by FcaRIIIA.
We have used a model system to study the role ofindividual Fc receptors, in transmission of a phagocytic signal. We observed that macrophage FcyRIIIA is able to mediate phagocytosis and that the y subunit of the receptor is essential both for surface expression and for signal transduction mediated by the receptor following activation. Future studies will examine the 
